Search Within

Wenbin Xiao

Formats
  1. Journal Article (50)
  2. Meeting Abstract (44)
  3. Research Letter (10)
  4. Review (8)
  5. Miscellaneous (2)
Groups
  1. Department of Pathology and Laboratory Medicine (114)
  2. Department of Medicine (84)
  3. Center for Hematologic Malignancies (83)
  4. Hematologic Malignancies, Division of (83)
  5. Adult Leukemia (73)
  6. GSK Faculty (53)

More Groups

People
  1. Mikhail Roshal (64)
  2. Yanming Zhang (49)
  3. Ross Levine (48)
  4. Ahmet Dogan (46)
  5. Maria Arcila (41)
  6. Jee Baik (30)

More People

Years
  1. 2025 (7)
  2. 2024 (17)
  3. 2023 (21)
  4. 2022 (10)
  5. 2021 (9)
  6. 2020 (18)

More Years

Publications
  1. Blood (35)
  2. Blood Advances (11)
  3. Laboratory Investigation (9)
  4. Modern Pathology (8)
  5. American Journal of Clinical Pathology (6)
  6. Haematologica (6)

More Publications

Publishers
  1. American Society of Hematology (46)
  2. Nature Publishing Group (17)
  3. Nature Research (8)
  4. Ferrata Storti Foundation (6)
  5. Oxford University Press (6)
  6. American Association for Cancer Research (3)

More Publishers

Results (114)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AML
    Journal Article

    Ball, B. J.; Xiao, W.; Borthakur, G.; Nguyen, L. X. T.; Valerio, M.; Venkatachalam, A.; Marcucci, G.; Stein, A. S.; Thai, D. L.; Cook, D. N.; more...
    Journal of Hematology & Oncology (2025)

    Fulltext@MSK | Save
  • Temporal clonal relatedness between myeloid neoplasm and nodal T-follicular helper cell lymphoma: A retrospective study
    Research Letter

    Yan, M.; Stuver, R.; Lin, K. S.; Johnson, W. T.; Horwitz, S. M.; Dogan, A.; Xiao, W.
    Blood Neoplasia (2025)

    Fulltext@MSK | Save
  • Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction
    Journal Article

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Benchmarking spleen tyrosine kinase (Syk) expression in T- and NK-cell neoplasms: Implications for therapeutic targeting
    Research Letter

    Zhang, J. P.; Gao, Q.; Jungbluth, A. A.; El Daker, S.; Sun, X.; Chan, A.; Xiao, W.; Roshal, M.; Dogan, A.; Sethi, S.
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
    Journal Article

    Galera, P.; Dilip, D.; Derkach, A.; Chan, A.; Zhang, Y.; Persaud, S.; Mishra, T.; Kramer, K.; Kathpalia, M.; Liu, Y.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Transcriptional activation of regenerative hematopoiesis via microenvironmental sensing
    Journal Article

    Itkin, T.; Houghton, S.; Schreiner, R.; Lin, Y.; Badwe, C. R.; Voisin, V.; Murison, A.; Seyedhassantehrani, N.; Kaufmann, K. B.; Garcia-Prat, L.; more...
    Nature Immunology (2025)

    Fulltext@MSK | Save
  • Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from TET2-/ DNMT3A-mutant clonal hematopoiesis in follicular helper T-cell lymphomas
    Research Letter

    Lewis, N. E.; Petrova-Drus, K.; Sardana, R.; Huet, S.; Gao, Q.; Sethi, S.; Vanderbilt, C.; Xiao, W.; Roshal, M.; Baik, J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • A multi-site break through cancer trial: Phase II study investigating dual inhibition of BCL2 and menin in AML MRD using the combination of venetoclax and revumenib (trial in progress)
    Meeting Abstract

    Issa, G. C.; Ambinder, A. J.; Xiao, W.; Manalis, S.; Shalek, A. K.; Gondek, L. P.; Kentsis, A.; Short, N. J.; Daver, N.; Ning, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Adult AML patients with NUP98 fusions are frequently therapy-related, and are associated with monocytic differentiation, recurring mutations in NRAS, DNMT3A and WTI and poor outcome
    Meeting Abstract

    Yao, J.; Aypar, U.; Sethi, S.; Boussi, L.; Londono, D.; Sukhadia, P.; Berman, E.; Stein, E. M.; Dogan, A.; Xiao, W.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patients with AML and an IDH2-R172 mutation exhibit a unique response to intensive induction chemotherapy, suggesting futility of mid-cycle bone marrow biopsy and caution when considering re-induction
    Meeting Abstract

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood (2024)

    Fulltext@MSK | Save